ABC | Volume 113, Nº4, Outubro 2019

Atualização Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(4):787-891 617. MozaffarianD, Liu J, Sy S, Huang Y, RehmC, Lee Y, et al. Cost-effectiveness of financial incentives and disincentives for improving food purchases and healththroughtheUSSupplementalNutritionAssistanceProgram (SNAP): A microsimulation study. PLoS Med. 2018;15(10):e1002661. 618. LeeY,MozaffarianD,SyS,HuangY,Liu J,WildePE,etal.Cost-effectiveness of financial incentives for improving diet and health throughMedicare and Medicaid: A microsimulation study. PLoS Med. 2019;16(3):e1002761. 619. Silveira EAD, Vieira LL, Jardim TV, Souza JD. Obesity and its Association with Food Consumption, Diabetes Mellitus, and Acute Myocardial Infarction in the Elderly. Arq Bras Cardiol. 2016;107(6):509-17. 620. Olsen, MH, Angell SY, Asma S; Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet, 2016;388(10060):2565-712. 621. Weintraub WS; Daniels SR; Burke LE; Franklin, BA, Goff Jr DC; Hayman LL, et al. AmericanHeart Association Advocacy Coordinating Committee, Council on Cardiovascular Disease in the Young, Council on the Kidney in CardiovascularDisease,CouncilonEpidemiologyandPrevention,Council on Cardiovascular Nursing, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Clinical Cardiology, and Stroke Council. Value of Primordial and Primary Prevention for Cardiovascular Disease A Policy Statement From the American Heart Association. Circulation. 2011;124(8):967–90. 622. Piepoli MF, Hoes AW, Agewall S, 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention&Rehabilitation (EACPR).Eur JPrevCardiol.2016;69(10):939. 623. Eckel RH, Jakicic JM, Ard JD, Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2014; 63(25Pt):2960-84. 624. Arena R, Guazzi M, Lianov L, Whitsel L, Bevia K, Lavie CJ, et al. and the AHA Writing Group, the ESC/EACPR Writing Group, and the ACPM Writing Group. Healthy lifestyle interventions to combat noncommunicabledisease-anovelnonhierarchicalconnectivitymodel for key stakeholders: a policy statement from the AmericanHeart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine. Eur Heart J. 2015;36(31):2097-109. 625. Vandevijvere S, Barquera S, Caceres G, Corvalan C, Karupaiah T, Kroker- Lobos MF, et al. An 11-country study to benchmark the implementation of recommended nutrition policies by national governments using the Healthy Food Environment Policy Index, 2015-2018. Obes Rev. 2019 Jan 4 [Epub ahead print] 626. Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J AmColl Cardiol. 2016;68(15):1609–17. 627. WorldHealthOrganization. (WHO). Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva;2013. 628. Anderson TJ, Gregoire J, Pearson GJ, Barry AR, Couture P, Dawes M, et al. 2016 Canadian Cardiovascular Society guidelines for themanagement of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32(11):1263-82. 629. Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood). 2007;26(1):13–24. 630. Ford ES, Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health. 2011 Apr;32:5–22. 631. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR. Explaining the decrease inU.S. deaths fromcoronary disease, 1980–2000. N Engl J Med. 2007;356(23):2388–98. 632. Shroufi A, Chowdhury R, Anchala R, Stevens S, Blanco P, Han T. Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. BMC Public Health. 2013 Mar;13:285. 633. Puska P, Nissinen A, Tuomilehto J, Salonen JT, Koskela K. The community- based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health. 1985 May;6:147–93. 634. Ryan A, Heath S, Cook P. Managing dyslipidaemia for the primary prevention of cardiovascular disease. BMJ. 2018 Mar;360:K946. 635. Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC Jr, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124(8):967–90. 636. Vandevijvere S, ChowCC, Hall KD, Umali E, Swinburn BA. Increased food energy supply as a major driver of the obesity epidemic: a global analysis. Bull World Health Organ. 2015;93(7):446–56. 637. Fortmann SP, Williams PT, Hulley SB, Haskell WL, Farguhar JW. Effect of health education on dietary behavior: the Stanford Three Community Study. Am J Clin Nutr. 1981;34(10):2030–8. 638. Fortmann SP, Taylor CB, Flora JA,WinklbyMA. Effect of community health education on plasma cholesterol levels and diet: the Stanford Five-City Project. Am J Epidemiol. 1993;137(10):1039–55. 639. Andrade JP, Arnett D, Pinto F. Tratado de prevenção cardiovascular: um desafio global. São Paulo; Editora Atheneu; 2014. 640. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;WorldHeart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):640-5. 641. GurkaMJ, Filipp SL, DeBoerMD. Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults. Nutrition Diabetes. 2018;8(1):14. 642. Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia- pacific region: a systematic review. BMC Public Health. 2017;17(1):101. 643. Whelton PK, Carey RM, AronowWS, Casey DE Jr, Collins KJ,Himmelfarb CD, et al. 2017ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71(19):e127-e248. 644. Diretrizes da Sociedade Brasileira de Diabetes 2017-2018 / organização José Egídio Paulo deOliveira, RenanMagalhãesMontenegro Junior, Sérgio Vencio. São Paulo: Editora Clannad, 2017. 645. Motamed N, Rabiee B, Roozafzai F, Zamani F, Faraji AH, Maadi M, et al. Metabolic syndrome and cardiovascular risk assessment tools' estimations of 10-year cardiovascular risk: a population-based study. Acta Cardiol. 2017 Nov;30:1-8. 646. American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care 2018;41(5):917–28. 647. Pedro-Botet J, Ascaso JF, Barrios V, De la Sierra A, Escalada J, Millán J, et al. COSMIC project: consensus on the objectives of themetabolic syndrome in clinic. Diabetes Metab Syndr Obes. 2018 Oct 31;11:683-97. 890